Navigation Links
Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
Date:9/14/2007

- FINANCIAL TABLES TO FOLLOW -

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

Three months ended June 30, Year ended June 30,

2007 2006 2007 2006

REVENUES

Royalty income $1,901,000 1,377,000 $6,853,000 $5,063,000

Technology sale

and collaboration

services 2,093,000 2,946,000 10,820,000 7,276,000

Total revenues 3,994,000 4,323,000 17,673,000 12,339,000

EXPENSES

Research and

development 7,508,000 7,944,000 26,737,000 22,808,000

Acquired in-process

research

and development -- -- -- 11,501,000

General and

administrative 1,792,000 1,225,000 6,537,000 5,968,000

Total expenses 9,300,000 9,169,000 33,274,000 40,277,000

Operating loss (5,306,000) (4,846,000) (15,601,000) (27,938,000)

Non-cash gain on

change in fair

value of warrants 980,000 -- 980,000 --

Investment income 140,000 171,000 494,000 399,000

Loss before

income tax $(4,186,000) $(4,675,000) $(14,127,000) $(27,539,000)

Provision for

income taxes -- 170,000 -- 300,000

NET LOSS $(4,186,000) $(4,845,000) $(14,127,000) $(27,839,000)

BASIC and DILUTED NET

LOSS PER SHARE $(0.13) $(0.16) $(0.47) $(0.98)

Shares used in basic

and diluted net

loss per share

calculation 32,685,615 29,546,326 30,364,114 28,490,373

SELECTED CONSOLIDATED BALANCE SHEET DATA

June 30, June 30,

2007 2006

'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... materialise. Yet, scientists are making progress in devising ... such approach relies on quantum dotsa kind of ... field. A new study demonstrates that changing the ... with electrical impulses can help better control them. ... used as quantum information units, which would produce ...
(Date:7/24/2014)... Although most natural and synthetic processes prefer to ... potential or energyit is within the realm of ... experience constant changes in energy and phases, such ... These conditions allow humans to regulate their body ... rumble with seismic activity. , But even ...
(Date:7/24/2014)... -- Research and Markets has announced the ... Instruments Market 2014-2018" report to their offering. ... is the study of the gene and its functions ... functions of proteomes or sets of proteins by using ... the mapping of genes and DNA sequencing to understand ...
(Date:7/24/2014)... 24, 2014 SRI International has been awarded ... Institute of Allergy and Infectious Diseases (NIAID), part of ... of potential therapies for HIV infection and AIDS. The ... and AIDS and the complications and opportunistic infections associated ... sexual transmission of HIV. According to ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3
... NORWOOD, Mass., Nov. 19 Advanced Instruments, ... has acquired 100% of the,shares of Mart ... of the,transaction were not disclosed. Mart ... of,instruments. These systems create custom environments for ...
... on Smart Coatings Cites Immediate Opportunities in ... Paint, and Smart Glass -, LITTLE FALLS, N.J., ... that they will no longer reimburse expenses related,to most ... and coatings industries to sell antimicrobial coatings,according to analysts ...
... Siemens Medical Solutions, (http://www.usa.siemens.com/healthcareit ) continues ... clinical and financial workflows through,Soarian(R), its next-generation, ... Assembly and Annual Meeting of the,Radiological Society ... to 30 at,McCormick Place in Chicago (Booth ...
Cached Biology Technology:Advanced Instruments Acquires Mart Microbiology B.V. 2Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S. 2Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian 2Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian 3
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... CINCINNATIBacterial contamination in water-damaged buildings has been identified ... infection and respiratory conditions like asthma. Which specific ... unknownmaking it difficult for public health officials to ... of the problem. In a new ...
... Review, 2012 -- a new congressionally mandated report from ... Comprehensive Everglades Restoration Plan (CERP), a multibillion-dollar, joint federal ... decline while meeting growing demands for clean water and ... CERP, which was launched in 2000 by the U.S. ...
... study published in the June 2012 issue of the ... found that young children who have been investigated for ... mental health problems and that very few receive treatment for ... Child and Adolescent Well-Being II (NSCAW II), a group of ...
Cached Biology News:Research identifies specific bacteria linked to indoor water-damage and mold 2Child welfare investigation predicts mental health problems in young children 2
ERalpha (Ser 104/106)...
... while maintaining high cell viability , ... , Fast: less than one ... , Highly reproducible results from ... with the Bio-Rad Gene Pulser Xcell System ...
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Mouse CXCR3 Allophycocyanin MAb (Clone 220803)...
Biology Products: